studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment initiative: Other fundingAgency: Other
Drop files to upload
S462_TNOres_gDNA_vs_S462_Par_gDNA.strelka.somatic_indels.TsTv.qual page is loading…